Loading...
c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells
Induced pluripotent stem cell (iPS) technology has launched a new platform in regenerative medicine aimed at deriving unlimited replacement tissue from autologous sources through somatic cell reprogramming using stemness factor sets. In this way, authentic cardiomyocytes have been obtained from iPS...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2835311/ https://ncbi.nlm.nih.gov/pubmed/20221419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-009-9150-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|